"Interleukin-33" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the INTERLEUKIN-1 protein family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage.
Below are MeSH descriptors whose meaning is more general than "Interleukin-33".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-33".
This graph shows the total number of publications written about "Interleukin-33" by people in this website by year, and whether "Interleukin-33" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Interleukin-33" by people in Profiles.
TGF-?1 Suppresses IL-33-Induced Mast Cell Function. J Immunol. 2017 08 01; 199(3):866-873.
Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1a-Dependent miR-155 Suppression. J Immunol. 2016 10 01; 197(7):2909-17.
Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity. J Leukoc Biol. 2016 12; 100(6):1395-1404.
Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int J Nanomedicine. 2013; 8:1733-48.
A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small. 2012 Sep 24; 8(18):2904-12.
Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine. 2012 Jun; 58(3):368-79.